Molecular diagnostics firm Biocartis has launched Idylla GeneFusion Assay as a rapid lab workflow solution for gene fusion testing.
BioVaxys has signed an agreement with Bioanalytical Systems (Inotiv) to conduct preclinical toxicity studies for its Covid-T immunodiagnostic programme.
CureApp has announced the completion of a Phase III clinical trial of its digital therapeutic app (DTx) in Japan to treat hypertension.
The US Food and Drug Administration (FDA) has granted approval to Boston Scientific’s TheraSphere Y-90 Glass Microspheres technology to treat patients with hepatocellular carcinoma (HCC).
Altasciences, in collaboration with the National Research Council of Canada (NRC), has qualified a quantitative serological assay to detect the presence of SARS-CoV-2 IgG antibodies.
Give your business an edge with our leading industry insights.
The US Food and Drug Administration (FDA) has granted marketing authorisation to BioFire Diagnostics’ SARS-CoV-2 test.
GenScript Biotech’s subsidiary GenScript Biotech Singapore has signed an agreement with UAE’s G42 Healthcare for exploring new solutions to fight against Covid-19.
PerkinElmer’s subsidiary EUROIMMUN has introduced the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope with EUROLabOffice 4.0 (ELO 4.0) software for modern diagnostics.
Researchers at the University of Rhode Island (URI) in the US have developed a saliva-based test to detect the Covid-19 virus.
MicroPort Orthopedics has announced that it witnessed increased adoption of its Kinematic Alignment (KA) approach for the Evolution Medial-Pivot knee system to improve patient outcomes.